众生药业跌2.02%，成交额8.97亿元，主力资金净流出6726.74万元

Core Viewpoint - The stock of Zhongsheng Pharmaceutical has experienced fluctuations, with a recent decline of 2.02% and a total market capitalization of 18.936 billion yuan, despite an overall increase of 86.44% year-to-date [1] Financial Performance - For the period from January to September 2025, Zhongsheng Pharmaceutical reported a revenue of 1.889 billion yuan, a year-on-year decrease of 1.01%, while the net profit attributable to shareholders increased by 68.40% to 251 million yuan [2] - The company has cumulatively distributed 2.019 billion yuan in dividends since its A-share listing, with 502 million yuan distributed over the past three years [3] Stock Market Activity - The stock has seen significant trading activity, with a net outflow of 67.267 million yuan in major funds recently, and it has appeared on the trading leaderboard seven times this year [1] - The stock price has fluctuated, with a recent 5-day decline of 5.75% and a 20-day increase of 20.89% [1] Shareholder Structure - As of September 30, 2025, the number of shareholders decreased by 18.90% to 72,900, while the average number of circulating shares per person increased by 23.31% to 10,445 shares [2] - Notable institutional shareholders include Hong Kong Central Clearing Limited and several funds from Xingquan, indicating a mix of new and increasing positions among major shareholders [3]